Objective: Examine the relationship between direct-to-consumer advertising (DTCA) expenditure and prescription drug price from 1997 to 2000 for the top 20 advertised drugs of 1998. Method: The 20 prescription drugs were selected based on DTCA expenditure for 1998 as published in Med AD News. Drug prices were determined using the average wholesale price. Trend graphs were plotted between DTCA expenditure and unit price. The correlation coefficient was calculated between percent change in DTCA expenditure and unit price between 1998 and 2000.
Results: There was a negative nonsignificant correlation between the percent change in DTCA expenditure and unit price between 1998 and 2000. All drugs had an increase in price but only half of the drugs showed an increase in percent change in DTCA expenditure whereas, the other half had a decrease in DTCA expenditure.
Conclusion: Even though every year the industry spends millions of dollars on DTCA of prescription drugs we cannot conclude that it influences drug prices.
FeisullinSSauseRB. Update on direct-to-consumer advertising of prescription drugs. Am Pharmacy.1991;NS31 (7):47–52.
2.
SmeedingJE. Direct-to-consumer advertising of prescription pharmaceuticals: Strategic issues for the pharmaceutical industry. Topics Hospital Pharmacy Manage. 1990; 10(1):40–64.
3.
CohenE. Direct-to-the public advertisement of prescription drugs. New Engl J Med.1988; 318(6):373–376.
4.
Direct-to-consumer advertisement of prescription drugs: Withdrawal of moratorium. Federal Register. 1985; 50:36677–36678.
5.
FindlaySD. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers. Pharmacoecon.2001; 19(2):109–119.
6.
ScussaF. Consumer ads reach peak. Med Ad News. June 2002; 21(6):1–8.
7.
Direct-to-consumer advertising.Med Ad News. June 2003; 22(6):42–51.
8.
RosenthalMBBerndtERDonohueJMPromotion of prescription drugs to consumers. New Engl J Med.2002; 346(7):498–505.
9.
U.S. Food and Drug Administration.Attitudes and Behaviors Associated with Direct-To-Consumer Promotion Of Prescription Drugs. Rockville, MD: U.S. Food and Drug Administration, Center for Drug Evaluation and Research; 1999. www.fda.gov/cder/ddmac/research.htm. (Accessed November 2002).
10.
KeithA. The benefits of pharmaceutical promotion: An economic and health perspective. J Pharma Market Manage. 1992; 7(1):121–133.
11.
HolmerAF. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA. 1999; 281(4):380–382.
12.
ColfordP. DTC ads: Just what the doctor ordered. Mediaweek. 1997; 7(39):46–48.
13.
FriedlerE. The evolving doctor-patient to provider-consumer relationship. J Family Practice. 1997; 45(6):35–36.
14.
Prevention Magazine. National survey of consumer reactions to direct-to-consumer advertising. Eammus, PA: Rodale Inc. Prevention Magazine; 1999.
15.
SlaughterESchumacherM.International survey on wellness and consumer reaction to DTC advertising of Rx drugs. Eammus, PA: Rodale Inc. Prevention Magazine; 2000/2001.
16.
Prevention Magazine. National Survey of Consumer Reactions to Direct-To-Consumer Advertising. Eammus, PA: Rodale Inc., Prevention Magazine; 1998.
17.
BenhamLBenhamA. Regulating through the health profession: A perspective information control. J Law Econ.1975; 18(2):421–447.
18.
HollonM. Direct-to-consumer marketing of prescription drugs. JAMA. 1999; 281:382–384.
19.
WhyteM. Direct-to-consumer advertising of prescription drugs. JAMA. 1993; 269:146.
20.
SchwartzRKSoumeraiSBAvornJ. Physician motivations for nonscientific drug prescribing. Social Sci Med.1989; 28(6):577–582.
21.
SlaughterE.An assessment of consumer reaction to direct-to-consumer advertising. Presented at the American Pharmaceutical Association, March 9, 1999, San Antonio, Texas.
22.
WilkesMSBellRAKravitzRL. Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Aff.2000; 19(2):110–128.
23.
Barents Group LLC for the National Institute for Health Care Management. Issue brief: Factors affecting the growth of prescription drugs expenditures. Barents Group LLC for the National Institute for Health Care Management; July 1999. www.nihcm.org. (Accessed January 2002).
24.
FindlayS.Research Brief: Prescription drugs and mass media advertising. National Institute for Health Care Management; September 2000. www.nihcm.org. (Accessed December 2002).
25.
CareyJBarrettA. Drug prices: what's fair?, In Business Week. December 10, 2001; 61–70.
26.
Kaiser Family Foundation.Prescription drug trends—a chart book update. Kaiser Family Foundation; November 2001. www.kff.org. (Accessed February 2002).
27.
Families USA.Enough to make you sick: prescription drug prices for the elderly. Families USA; June 2001. http://www.familiesusa.org. (Accessed February 2002).
28.
ZachryWIIIShepherdMDHinichMJRelationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am J Health System Pharmacy. 2002; 59(1):42–49.
29.
National Center for Health Care Statistics/Centers for Disease Control and Prevention. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 1999 summary. National Center for Health Care Statistics/Centers for Disease Control and Prevention; 2001. http://www.cdc.gov/nchs/data/ad/ad322.pdf. (Accessed December 2002).
30.
NeslinS.ROI analysis of pharmaceutical promotion (RAPP): An independent study 2001. www.rappstudy.org. (Accessed December 2002).
31.
JohnsonST. Direct-to-consumer advertising and rising prescription drug prices. Delivered to the U.S. Senate, 2000.
32.
United States General Accounting Office.Prescription Drugs: FDA Oversight of Direct-to-Consumer has Limitations. Washington, DC: United States General Accounting Office, Report to Congressional Requesters; October 2002 GAO-03–177.
33.
KoppSW. Direct-to-consumer advertising and consumer prescription prices. Drug Inf J.1996; 30:59–65.
34.
MathewsMJr.Who's afraid of pharmaceutical advertising: A response to a changing health care system. Institute for Policy Innovation; May 2001, Policy report 155. http://www.ipi.org. (Accessed July 2002).
35.
HansenRAgrawalS. Exploring the relationship of direct-to-consumer advertising and prescription drug prices. Annual Meeting Abstracts. J Am Pharma Assoc.2002; 42(2):322.
FarrisPWAlbionMS. The impact of advertising on the price of consumer products. J Market. 1980; 44:17–35.
38.
SheffetMJKoppSW. Advertising prescription drugs to the public: Headache or relief. J Public Policy Market. 1990; 9(2):42–62.
39.
Prevention Magazine and the American Pharmaceutical Association. Navigating the Medical Marketplace: How Consumers Choose. Washington, DC: Prevention Magazine and the American Pharmaceutical Association; 1997.
40.
SlaughterE.Consumer reaction to DTC advertising of prescription medicines. Eammus, PA: Rodale Inc., Prevention Magazine; 2001/2002.
41.
Prescription medicines advertised to consumers and their ad expenditures (all media).Med Ad News. June 1999; 18(6): 18.
42.
FrankRBerndtERDonohueJTrends in direct-to-consumer advertising of prescription drugs. The Henry J. Kaiser Family Foundation 2002. www.kff.org. (Accessed December 2002).
43.
MorrisLAMazisMBBrinbergD. Risk disclosures in televised prescription drug advertising to consumers. J Public Policy Market. 1989; 8(1):64–80.
